All In Biotech

Drug Trial Radar · NCT05741476

Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Children 4-7 Years of Age

A Phase 3, Double-blind, Placebo-controlled, Randomized Study to Assess the Efficacy and Safety of Epicutaneous Immunotherapy With DBV712 250 μg in 4-7-year-old Children With Peanut Allergy (VITESSE)

Last checked: Nov 19, 2026Latest source record: Jan 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 600 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

600

Planned (sponsor's estimate)

Start

Feb 21, 2023

Primary completion

Nov 6, 2025

Study completion Oct 2029

Sponsor

Lead sponsor
DBV TechnologiesIndustry
Sponsor type
Industry
First posted
Feb 23, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 4 years, up to 7 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary purpose of this study is to assess the efficacy and safety of daily DBV712 250 micrograms (mcg) to induce desensitization to peanut in peanut-allergic children 4-7 years of age over a 12-month double-blind, placebo-controlled (DBPC) Treatment Period.

Conditions

  • Allergy, Peanut

Interventions

  • DBV712Drug

    DBV712 250 mcg epicutaneous system.

  • PlaceboOther

    DBV712 matching placebo epicutaneous system.

  • DBV712Drug

    DBV712 250 mcg epicutaneous system.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. DBPC Treatment Period: Percentage of Treatment Responders in the DBV712 250 mcg Group Compared to Placebo GroupTime frame: At Month 12

Locations

87 sites in 9 countries. Site status is shown where the registry gives one.

  • DBV Investigative Site

    Birmingham, Alabama

  • DBV Investigative Site

    Tucson, Arizona

  • DBV Investigative Site

    Little Rock, Arkansas

  • DBV Investigative Site

    Los Angeles, California

  • DBV Investigative Site

    Los Angeles, California

  • DBV Investigative site

    Mission Viejo, California

  • DBV Investigative Site

    San Diego, California

  • DBV Investigative Site

    San Francisco, California

  • DBV Investigative Site

    San Jose, California

  • DBV Investigative Site

    Aurora, Colorado

  • DBV Investigative Site

    Colorado Springs, Colorado

  • DBV Investigative Site

    Washington D.C., District of Columbia

  • DBV Investigative Site

    Hollywood, Florida

  • DBV Investigative Site

    Miami, Florida

  • DBV Investigative Site

    St. Petersburg, Florida

  • DBV Investigative Site

    Tampa, Florida

  • DBV Investigative site

    Atlanta, Georgia

  • DBV Investigative Site

    Marietta, Georgia

  • DBV Investigative Site

    Chicago, Illinois

  • DBV Investigative Site

    Normal, Illinois

  • DBV Investigative Site

    Indianapolis, Indiana

  • DBV Investigative Site

    Louisville, Kentucky

  • DBV Investigative Site

    Baltimore, Maryland

  • DBV Investigative Site

    Chevy Chase, Maryland

  • DBV Investigative Site

    Boston, Massachusetts

  • DBV Investigative Site

    Boston, Massachusetts

  • DBV Investigative Site

    Taunton, Massachusetts

  • DBV Investigative Site

    Ann Arbor, Michigan

  • DBV Investigative Site

    Ypsilanti, Michigan

  • DBV Investigative Site

    Maplewood, Minnesota

  • DBV Investigative Site

    Kansas City, Missouri

  • DBV Investigative Site

    Great Neck, New York

  • DBV Investigative Site

    New York, New York

  • DBV Investigative Site

    New York, New York

  • DBV Investigative Site

    Rochester, New York

  • DBV Investigative Site

    Chapel Hill, North Carolina

  • DBV Investigative Site

    Cincinnati, Ohio

  • DBV Investigative Site

    Cleveland, Ohio

  • DBV Investigative Site

    Cleveland, Ohio

  • DBV Investigative Site

    Columbus, Ohio

Showing 40 of 87 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.